5AMVENTURES.COM: Keyword Density Checker

Total words: 1164 | 2-word phrases: 301 | 3-word phrases: 326 | 4-word phrases: 334

PAGE INFO

Title	Try to keep the title under 60 characters (12 characters) 5AM Ventures
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (113 characters) 5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies

#	Keyword	Frequency	Density
1	under management 0	3	0.92%
2	therapeutics announces two	2	0.61%
3	and russell 3000®	2	0.61%
4	oncology enters into	2	0.61%
5	enters into strategic	2	0.61%
6	into strategic agreement	2	0.61%
7	strategic agreement with	2	0.61%
8	and life science	2	0.61%
9	skye bioscience added	2	0.61%
10	bioscience added to	2	0.61%
11	added to russell	2	0.61%
12	to russell 2000®	2	0.61%
13	russell 2000® and	2	0.61%
14	2000® and russell	2	0.61%
15	russell 3000® indexes	2	0.61%
16	of neurology ean	2	0.61%
17	rarecyte® secures 20m	2	0.61%
18	secures 20m financing	2	0.61%
19	20m financing to	2	0.61%
20	expand the orion™	2	0.61%
21	spatial biology platform	2	0.61%
22	biology platform including	2	0.61%
23	platform including multiplex	2	0.61%
24	including multiplex assay	2	0.61%
25	and precision biology	2	0.61%
26	precision biology services	2	0.61%
27	announces pricing of	2	0.61%
28	radionetics oncology enters	2	0.61%
29	agreement with lilly	2	0.61%
30	academy of neurology	2	0.61%

#	Keyword	Frequency	Density
1	two poster presentations for	2	0.60%
2	bioscience added to russell	2	0.60%
3	congress of the european	2	0.60%
4	of the european academy	2	0.60%
5	the european academy of	2	0.60%
6	european academy of neurology	2	0.60%
7	academy of neurology ean	2	0.60%
8	oncology enters into strategic	2	0.60%
9	enters into strategic agreement	2	0.60%
10	into strategic agreement with	2	0.60%
11	strategic agreement with lilly	2	0.60%
12	skye bioscience added to	2	0.60%
13	added to russell 2000®	2	0.60%
14	the 10th congress of	2	0.60%
15	to russell 2000® and	2	0.60%
16	russell 2000® and russell	2	0.60%
17	2000® and russell 3000®	2	0.60%
18	and russell 3000® indexes	2	0.60%
19	rarecyte® secures 20m financing	2	0.60%
20	secures 20m financing to	2	0.60%
21	spatial biology platform including	2	0.60%
22	biology platform including multiplex	2	0.60%
23	platform including multiplex assay	2	0.60%
24	and precision biology services	2	0.60%
25	10th congress of the	2	0.60%
26	radionetics oncology enters into	2	0.60%
27	at the 10th congress	2	0.60%
28	team news careers contact	2	0.60%
29	announces two poster presentations	2	0.60%
30	therapeutics announces two poster	2	0.60%
31	dianthus therapeutics announces two	2	0.60%
32	portfolio strategy team news	2	0.60%
33	upsized 1670 million initial	2	0.60%
34	1670 million initial public	2	0.60%
35	strategy team news careers	2	0.60%
36	million initial public offering	2	0.60%
37	financing to expand the	1	0.30%
38	to expand the orion™	1	0.30%
39	expand the orion™ spatial	1	0.30%
40	the orion™ spatial biology	1	0.30%